Benefits of vitamin D in reducing the risk of cancer: Time to include vitamin D in cancer treatment?

Journal of the Society for Integrative Oncology

Volumn 8, Issue 3, 2010, Pages 81-88

  Grant, William B ^a  

^a Sunlight Nutrition and Health Research Center ^*  (United States)

Author keywords

Cancer; Cathelicidin; Influenza; Prostate cancer; Septicemia; Ultraviolet B; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; APOLIPOPROTEIN E4; CALCIUM; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; PLACEBO; VITAMIN D; VITAMIN D RECEPTOR;

BLADDER CANCER; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER INHIBITION; CANCER MORTALITY; CANCER RISK; CANCER SURVIVAL; COLON CANCER; COLORECTAL CANCER; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG EFFICACY; ENDOMETRIUM CANCER; EVENT FREE SURVIVAL; HUMAN; HYPERCALCEMIA; LYMPHOMA; MALIGNANT NEOPLASTIC DISEASE; MELANOMA; MYELOMA; OBSERVATIONAL STUDY; OVARY CANCER; OVERALL SURVIVAL; PROSTATE CANCER; REVIEW; RISK BENEFIT ANALYSIS; RISK REDUCTION; SEPTICEMIA; SUN EXPOSURE; SYSTEMATIC REVIEW; ULTRAVIOLET B RADIATION; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

EID: 78751536086     PISSN: 1715894X     EISSN: None     Source Type: Journal    
DOI: 10.2310/7200.2010.0003     Document Type: Review

References (92)

1. Deng GE, Frenkel M, Cohen L, et al. Evidence-based clinical practice guidelines for integrative oncology: complementary therapies and botanicals. J Soc Integr Oncol 2009;7:85-120.
2. Garland CF, Garland FC. Do sunlight and vitamin D reduce the likelihood of colon cancer? Int J Epidemiol 1980;9:227-31.
3. Grant WB, Garland CF. The association of solar ultraviolet B (UVB) with reducing risk of cancer: multifactorial ecologic analysis of geographic variation in age-adjusted cancer mortality rates. Anticancer Res 2006;26:2687-99. (Pubitemid 44155550)
4. Boscoe FP, Schymura MJ. Solar ultraviolet-B exposure and cancer incidence and mortality in the United States, 1993-2000. BMC Cancer 2006;6:264.
5. Grant WB. An ecologic study of cancer mortality rates in Spain with respect to indices of solar UV irradiance and smoking. Int J Cancer 2007;120:1123-7.
6. Mohr SB. A brief history of vitamin D and cancer prevention. Ann Epidemiol 2009;19:79-83.
7. Grant WB, Mohr SB. Ecological studies of ultraviolet B, vitamin D and cancer since 2000. Ann Epidemiol 2009;19:446-54.
8. Leffell DJ, Brash DE. Sunlight and skin cancer. Sci Am 1996;275:52-3, 56-9.
9. Hyppönen E, Power C. Hypovitaminosis D in British adults at age 45 y: nationwide cohort study of dietary and lifestyle predictors. Am J Clin Nutr 2007;85: 860-8. (Pubitemid 46393520)
10. Heaney RP, Davies KM, Chen TC, et al. Human serum 25- hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr 2003;77:204-10. (Pubitemid 36015393)
11. Gorham ED, Garland CF, Garland FC, et al. Optimal vitamin D status for colorectal cancer prevention: a quantitative meta analysis. Am J Prev Med 2007;32:210-6. (Pubitemid 46223622)
12. Garland CF, Gorham ED, Mohr SB, et al. Vitamin D and prevention of breast cancer: pooled analysis. J Steroid Biochem Mol Biol 2007;103:708-11.
13. Grant WB. An estimate of premature cancer mortality in the U.S. due to inadequate doses of solar ultraviolet-B radiation. Cancer 2002;94:1867-75. (Pubitemid 34241126)
14. Grant WB. Lower vitamin-D production from solar ultraviolet-B irradiance may explain some differences in cancer survival rates. J Natl Med Assoc 2006;98:357-64. (Pubitemid 43352525)
15. Grant WB. The health benefits of solar irradiance and vitamin D and the consequences of their deprivation. Clin Rev Bone Mineral Metab 2009;7:134-46.
16. Garland CF, Garland FC, Gorham ED, et al. The role of vitamin D in cancer prevention. Am J Public Health 2006;96:252-61.
17. Giovannucci E, Liu Y, Rimm EB, et al. Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst 2006;98:451-9.
18. Kricker A, Armstrong BK, Hughes AM, et al. Personal sun exposure and risk of non Hodgkin lymphoma: a pooled analysis from the Interlymph Consortium. Int J Cancer 2008;122:144-54. (Pubitemid 350209989)
19. Ng K, Meyerhardt JA, Wu K, et al. Circulating 25-hydroxyvitamin D levels and survival in patients with colorectal cancer. J Clin Oncol 2008;26:2984-91.
20. Goodwin PJ, Ennis M, Pritchard KI, et al. Prognostic effects of 25-hydroxyvitamin D levels in early breast cancer. J Clin Oncol 2009;27:3757-63.
21. Drake MT, Maurer MJ, Link BK, et al. Vitamin D deficiency is associated with inferior event-free and overall survival in diffuse large B-cell lymphoma [abstract]. Presented at the 51st American Society of Hematology Annual Meeting; 2009 Dec 5-8; New Orleans. Available at: http://ash.confex.com/ash/2009/ webprogram/Paper 24656.html (accessed December 8, 2009).
22. Porojnicu AC, Lagunova Z, Robsahm TE, et al. Changes in risk of death from breast cancer with season and latitude: sun exposure and breast cancer survival in Norway. Breast Cancer Res Treat 2007;102:323-8. (Pubitemid 46474836)
23. Lim HS, Roychoudhuri R, Peto J, et al. Cancer survival is dependent on season of diagnosis and sunlight exposure. Int J Cancer 2006;119:1530-6. (Pubitemid 44258757)
24. Moan J, Porojnicu AC, Robsahm TE, et al. Solar radiation, vitamin D and survival rate of colon cancer in Norway. J Photochem Photobiol B 2005;78:189-93. (Pubitemid 40220986)
25. Lagunova Z, Porojnicu AC, Dahlback A, et al. Prostate cancer survival is dependent on season of diagnosis. Prostate 2007;67:1362-70. (Pubitemid 47435784)
26. Porojnicu AC, Robsahm TE, Ree AH, Moan J. Season of diagnosis is a prognostic factor in Hodgkin's lymphoma: a possible role of sun-induced vitamin D. Br J Cancer 2005;93:571-4. (Pubitemid 43080001)
27. Boniol M, Armstrong BK, Doré JF. Variation in incidence and fatality of melanoma by season of diagnosis in new South Wales, Australia. Cancer Epidemiol Biomarkers Prev 2006;15:524-6.
28. Köstner K, Denzer N, Müller CS, et al. The relevance of vitamin D receptor (VDR) gene polymorphisms for cancer: a review of the literature. Anticancer Res 2009;29:3511-36.
29. Tamez S, Norizoe C, Ochiai K, et al. Vitamin D receptor polymorphisms and prognosis of patients with epithelial ovarian cancer. Br J Cancer 2009 Nov 10. [Epub ahead of print]
30. Raimondi S, Johansson H, Maisonneuve P, Gandini S. Review and meta-analysis on vitamin D receptor polymorphisms and cancer risk. Carcinogenesis 2009;30:1170-80.
31. Braun MM, Helzlsouer KJ, Hollis BW, Comstock GW. Prostate cancer and prediagnostic levels of serum vitamin D metabolites (Maryland, United States). Cancer Causes Control 1995;6:235-9.
32. Tangrea J, Helzlsouer K, Pietinen P, et al. Serum levels of vitamin D metabolites and the subsequent risk of colon and rectal cancer in Finnish men. Cancer Causes Control 1997;8:615-25. (Pubitemid 27330494)
33. Wu K, Feskanich D, Fuchs CS, et al. A nested case control study of plasma 25-hydroxyvitamin D concentrations and risk of colorectal cancer. J Natl Cancer Inst 2007;99:1120-9. (Pubitemid 47241396)
34. Grant WB. What is the optimal serum 25-hydroxy-vitamin D level for the prevention of cancer? J Photochem Photobiol B: Biology. Submitted.
35. Lowe LC, Guy M, Mansi JL, et al. Plasma 25-hydroxy vitamin D concentrations, vitamin D receptor genotype and breast cancer risk in a UK Caucasian population. Eur J Cancer 2005;41:1164-9. (Pubitemid 40725575)
36. Bertone-Johnson ER, Chen WY, Holick MF, et al. Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 2005;14:1991-7. (Pubitemid 41161213)
37. Freedman DM, Chang SC, Falk RT, et al. Serum levels of vitamin D metabolites and breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev 2008;17:889-94. (Pubitemid 351536420)
38. Abbas S, Linseisen J, Slanger T, et al. Serum 25-hydroxy-vitamin D and risk of postmenopausal breast cancer - results of a large case-control study. Carcinogenesis 2008;29:93-9. (Pubitemid 351201746)
39. Abbas S, Chang-Claude J, Linseisen J. Plasma 25-hydroxy-vitamin D and premenopausal breast cancer risk in a German case-control study. Int J Cancer 2009;124:250-5.
40. Grant WB, Garland CF. A critical review of studies on vitamin D in relation to colorectal cancer. Nutr Cancer 2004;48:115-23.
41. Wactawski-Wende J, Kotchen JM, Anderson GL, et al. Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med 2006;354:684-96. (Pubitemid 43247139)
42. Holick MF, Giovannucci E, Wactawski-Wende J, et al. Calcium plus vitamin D and the risk of colorectal cancer. N Engl J Med 2006;354:2287-8. (Pubitemid 43788151)
43. Lappe JM, Travers-Gustafson D, Davies KM, et al. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr 2007;85:1586-91. (Pubitemid 46890428)
44. Hanchette CL, Schwartz GG. Geographic patterns of prostate cancer mortality. Evidence for a protective effect of ultraviolet radiation. Cancer 1992;70:2861-9.
45. Li H, Stampfer MJ, Hollis JB, et al. A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer. PLoS Med 2007;4:e103.
46. Ahn J, Peters U, Albanes D, et al. Serum vitamin D concentration and prostate cancer risk: a nested casecontrol study. J Natl Cancer Inst 2008;100:796-804. (Pubitemid 351809669)
47. Gilbert R, Metcalfe C, Oliver SE, et al. Life course sun exposure and risk of prostate cancer: population-based nested case-control study and meta-analysis. Int J Cancer 2009;125:1414-23.
48. Travis RC, Crowe FL, Allen NE, et al. Serum vitamin D and risk of prostate cancer in a case-control analysis nested within the European Prospective Investigation into Cancer and Nutrition (EPIC). Am J Epidemiol 2009;169:1223-32.
49. Gupta D, Lammersfeld CA, Trukova K, Lis CG. Vitamin D and prostate cancer risk: a review of the epidemiological literature. Prostate Cancer Prostatic Dis 2009;12:215-26.
50. Devesa SS, Grauman DJ, Blot WJ, et al. Atlas of cancer mortality in the United States, 1950-1994. Bethesda (MD): National Institutes of Health; 1999. NIH Publication No.: 99-4564. Available at: http://www3. cancer. gov/atlasplus/ (accessed December 8, 2009).
51. Brittingham A, de la Cruz GP. Ancestry 2000. Census 2000 Brief CK2BR-35. In: U. S. Department of Commerce Census Bureau, editor. Washington (DC): U.S. Census Bureau; 2004.
52. Grant WB. An ecological study of dietary and genetic risk factors for prostate cancer: cholesterol as an important factor. Anticancer Res. [In press]
53. Iso H, Ikeda A, Inoue M, et al. Serum cholesterol levels in relation to the incidence of cancer: the JPHC Study cohorts. Int J Cancer 2009;125:2679-86.
54. Albanes D, Weinstein SJ, Wright ME, et al. Serum insulin, glucose, indices of insulin resistance, and risk of prostate cancer. J Natl Cancer Inst 2009;101:1272-9.
55. Hallman DM, Boerwinkle E, Saha N, et al. The apolipoprotein E polymorphism: a comparison of allele frequencies and effects in nine populations. Am J Hum Genet 1991;49:338-49. (Pubitemid 21891679)
56. Tretli S, Hernes E, Berg JP, et al. Association between serum 25(OH)D and death from prostate cancer. Br J Cancer 2009;100:450-4.
57. Grant WB. Vitamin D may reduce prostate cancer metastasis by several mechanisms including blocking stat3. Am J Pathol 2008;173:1589-90.
58. Bonjour JP, Chevalley T, Fardellone P. Calcium intake and vitamin D metabolism and action, in healthy conditions and in prostate cancer. Br J Nutr 2007;97:611-6. (Pubitemid 46470667)
59. Grant WB. An ecologic study of dietary links to prostate cancer. Altern Med Rev 1999;4:162-9. (Pubitemid 29316279)
60. Peterlik M, Grant WB, Cross HS. Calcium, vitamin D and cancer. Anticancer Res 2009;29:3687-98.
61. Peterlik M, Cross HS. Vitamin D and calcium insufficiency-related chronic diseases: molecular and cellular pathophysiology. Eur J Clin Nutr 2009;63:1377-86.
62. Ingraham BA, Bragdon B, Nohe A. Molecular basis of the potential of vitamin D to prevent cancer. Curr Med Res Opin 2008;24:139-49. (Pubitemid 351160247)
63. Garland CF, Gorham ED, Mohr SB, Garland FC. Vitamin D for cancer prevention: global perspective. Ann Epidemiol 2009;19:468-3.
64. IARC Working Group Report 5: vitamin D and cancer. Lyon (France): International Agency for Research on Cancer; Nov. 25, 2008.
65. Grant WB. A critical review of vitamin D and cancer: a report of the IARC Working Group on vitamin D. Dermato-Endocrinology 2009;1:25-33.
66. Hill AB. The environment and disease: association or causation? Proc R Soc Med 1965;58:295-300.
67. Grant WB. How strong is the evidence that solar ultraviolet B and vitamin D reduce the risk of cancer? An examination using Hill's criteria for causality. Dermato-Endocrinology 2009;1:14-21.
68. Grant WB, Boucher BJ. Current impediments to acceptance of the ultraviolet-B-vitamin D-cancer hypothesis (review). Anticancer Res 2009;29:3597-604.
69. Looker AC, Pfeiffer CM, Lacher DA, et al. Serum 25-hydroxyvitamin D status of the US population: 1988-1994 compared with 2000-2004. Am J Clin Nutr 2008;88:1519-27.
70. Ginde AA, Liu MC, Camargo CA Jr. Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. Arch Intern Med 2009;169:626-32.
71. Bischoff-Ferrari HA, Shao A, Dawson-Hughes B, et al. Benefit-risk assessment of vitamin D supplementation. Osteoporos Int 2009 Dec 3. [Epub ahead of print]
72. Houghton LA, Vieth R. The case against ergocalciferol (vitamin D2) as a vitamin supplement. Am J Clin Nutr 2006;84:694-7. (Pubitemid 44715649)
73. Douard V, Asgerally A, Sabbagh Y, et al. Dietary fructose inhibits intestinal calcium absorption and induces vitamin D insufficiency in CKD. J Am Soc Nephrol 2009 Dec 3. [Epub ahead of print]
74. Benjamin A, Moriakova A, Akhter N, et al. Determinants of 25-hydroxyvitamin D levels in African-American and Caucasian male veterans. Osteoporos Int 2009;20:1795-803.
75. Yavuz B, Ertugrul DT, Cil H, et al. Increased levels of 25 hydroxyvitamin D and 1,25-dihydroxyvitamin D after rosuvastatin treatment: a novel pleiotropic effect of statins? Cardiovasc Drugs Ther 2009;23:295-9.
76. Webb AR, Engelsen O. Calculated ultraviolet exposure levels for a healthy vitamin D status. Photochem Photobiol 2006;82:1697-703. (Pubitemid 46158866)
77. Lagunova Z, Porojnicu AC, Lindberg F, et al. The dependency of vitamin D status on body mass index, gender, age and season. Anticancer Res 2009;29:3713-20.
78. Grant WB. In defense of the sun: an estimate of changes in mortality rates in the United States if mean serum 25-hydroxyvitamin D levels were raised to 45 ng/mL by solar ultraviolet-B irradiance. Dermato- Endocrinology 2009;1:207-14.
79. Hathcock JN, Shao A, Vieth R, Heaney R. Risk assessment for vitamin D. Am J Clin Nutr 2007;85:6-18. (Pubitemid 46067609)
80. Seymour JF, Gagel RF, Hagemeister FB, et al. Calcitriol production in hypercalcemic and normocalcemic patients with non-Hodgkin lymphoma. Ann Intern Med 1994;121:633-40.
81. Adams JS. Vitamin D metabolite-mediated hypercalcemia. Endocrinol Metab Clin North Am 1989;18:765-78. (Pubitemid 19233015)
82. White JH. Vitamin D signaling, infectious diseases, and regulation of innate immunity. Infect Immun 2008; 76:3837-43.
83. Cannell JJ, Zasloff M, Garland CF, et al. On the epidemiology of influenza. Virol J 2008;5:29.
84. Grant WB, Giovannucci E. The possible roles of solar ultraviolet-B radiation and vitamin D in reducing casefatality rates from the 1918-1919 influenza pandemic in the United States. Dermato-Endocrinology 2009;1:215-9.
85. Grant WB. Solar ultraviolet-B irradiance and vitamin D may reduce the risk of septicemia. Dermato-Endocrinology 2009;1:37-42.
86. Jeng L, Yamshchikov AV, Judd SE, et al. Alterations in vitamin D status and anti-microbial peptide levels in patients in the intensive care unit with sepsis. J Transl Med 2009;7:28.
87. Giovannucci E, Liu Y, Hollis BW, Rimm EB. 25-Hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med 2008;168:1174-80. (Pubitemid 351831400)
88. Dobnig H, Pilz S, Scharnagl H, et al. Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch Intern Med 2008;168:1340-9. (Pubitemid 351930842)
89. Ginde AA, Scragg R, Schwartz RS, Camargo CA Jr. Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older U.S. adults. J Am Geriatr Soc 2009;57:1595-603.
90. Autier P, Gandini S. Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch Intern Med 2007;167:1730-7. (Pubitemid 47403059)
91. Holick MF. Vitamin D deficiency. N Engl J Med 2007;357:266-81.
92. Cannell J, Hollis B, Zasloff M, Heaney R. Diagnosis and treatment of vitamin D deficiency. Expert Opin Pharmacother 2008;9:107-18. (Pubitemid 351233752)